- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy ; volume:7 ; number:1 ; day:10 ; month:7 ; year:2019 ; pages:1-7 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (10.7.2019), 1-7, 12.2019
- Creator
-
Dama, Paola
Tang, Marshall
Fulton, Noreen
Kline, Justin
Liu, Hongtao
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0611-3
- URN
-
urn:nbn:de:101:1-2019112211303369701255
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dama, Paola
- Tang, Marshall
- Fulton, Noreen
- Kline, Justin
- Liu, Hongtao
- SpringerLink (Online service)
Other Objects (12)
FAiL | twice! | fail
Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy
"AML!
AML
AML
AML
AML
Early changes in gene expression profiles in AML patients during induction chemotherapy
Prof. Fail
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
EASt AML
Aml Ameen
FAiL | twice! | fail
Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy
"AML!
AML
AML
AML
AML
Early changes in gene expression profiles in AML patients during induction chemotherapy
Prof. Fail
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
EASt AML
Aml Ameen
FAiL | twice! | fail
Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy
"AML!
AML
AML
AML
AML
Early changes in gene expression profiles in AML patients during induction chemotherapy
Prof. Fail
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
EASt AML